Translation Medicine Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Institute of Health Sciences, Chinese Academy of Sciences and Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cancer Res. 2018 Jun 1;78(11):2825-2838. doi: 10.1158/0008-5472.CAN-17-2314. Epub 2018 Mar 12.
Posttranslational modifications of mammalian c-Src N-terminal and C-terminal domains regulate distinct functions. Myristoylation of G controls its cell membrane association and phosphorylation of Y419/Y527 controls its activation or inactivation, respectively. We provide evidence that Src-cell membrane association-dissociation and catalytic activation-inactivation are both regulated by acetylation. In EGF-treated cells, CREB binding protein (CBP) acetylates an N-terminal lysine cluster (K5, K7, and K9) of c-Src to promote dissociation from the cell membrane. CBP also acetylates the C-terminal K401, K423, and K427 of c-Src to activate intrinsic kinase activity for STAT3 recruitment and activation. N-terminal domain phosphorylation (Y14, Y45, and Y68) of STAT3 by c-Src activates transcriptionally active dimers of STAT3. Moreover, acetyl-Src translocates into nuclei, where it forms the Src-STAT3 enhanceosome for gene regulation and cancer cell proliferation. Thus, c-Src acetylation in the N-terminal and C-terminal domains play distinct roles in Src activity and regulation. CBP-mediated acetylation of lysine clusters in both the N-terminal and C-terminal regions of c-Src provides additional levels of control over STAT3 transcriptional activity. .
哺乳动物 c-Src N 端和 C 端结构域的翻译后修饰调节不同的功能。G 的豆蔻酰化控制其细胞膜结合,而 Y419/Y527 的磷酸化分别控制其激活或失活。我们提供的证据表明,Src-细胞膜结合-解离和催化激活-失活都受到乙酰化的调节。在 EGF 处理的细胞中,CREB 结合蛋白 (CBP) 乙酰化 c-Src 的 N 端赖氨酸簇 (K5、K7 和 K9),以促进其与细胞膜解离。CBP 还乙酰化 c-Src 的 C 端 K401、K423 和 K427,以激活固有激酶活性,募集和激活 STAT3。c-Src 对 STAT3 的 N 端结构域磷酸化 (Y14、Y45 和 Y68) 激活转录活性的 STAT3 二聚体。此外,乙酰化的 c-Src 易位到细胞核,在那里它形成 Src-STAT3 增强子复合物,用于基因调控和癌细胞增殖。因此,c-Src 在 N 端和 C 端结构域的乙酰化在 Src 活性和调节中发挥不同的作用。CBP 介导的 c-Src 的 N 端和 C 端区域赖氨酸簇的乙酰化提供了对 STAT3 转录活性的额外控制水平。